犬流感疫苗市場：依疫苗類型、病毒類型、通路和地區分類。

Canine Influenza Vaccine Market, By Vaccine Type, By Virus Type, By Distribution Channel, By Geography

出版日期: 2026年03月27日 | 出版商:

Coherent Market Insights | 英文 169 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年全球犬流感疫苗市場規模估計為20.062億美元，預計2033年將達到29.184億美元。預計2026年至2033年，該市場將以5.5%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	20.062億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	5.50%	2033年市場規模預測：	29.184億美元

犬流感（俗稱狗流感）是一種由犬流感病毒引起的傳染性呼吸道疾病。主要症狀包括咳嗽、流鼻水和發燒。大多數犬隻可在2-3週內康復，但對於幼犬、老年犬或患有嚴重疾病的犬隻而言，犬流感可能致命。全球犬流感疫苗市場的主要驅動力是全球病例數的不斷增加。人們對該疾病的認知不斷提高以及有效疫苗的普及正在推動市場成長。然而，缺乏強制性疫苗接種政策以及疫苗生產高成本正在阻礙市場潛力的發展。整體而言，為開發新的疫苗株而進行的大量研發活動，將在未來幾年為市場擴張創造機會。

市場動態

受全球犬流感感染病例不斷增加的推動，全球犬流感疫苗市場正經歷強勁成長。研究表明，該病毒已在北美、亞太地區和多個歐洲國家廣泛傳播。作為伴侶動物飼養的犬隻數量不斷成長，加上犬舍、犬展和公園等場所寵物密度高，加劇了疾病的快速蔓延。這使得寵物飼主和犬舍對有效的犬流感疫苗的需求日益成長。然而，疫苗生產所需的大量資金投入，以及一些低度開發地區缺乏標準化的群體免疫政策，阻礙了市場成長。此外，新冠肺炎疫情造成的供應鏈中斷也帶來了短期挑戰。展望未來，政府機構、疫苗研發人員和獸醫之間加強合作，提高大眾對犬流感及其疫苗接種重要性的認知，將創造新的機會。

本次調查的主要特點

本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球犬流感疫苗市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球犬流感疫苗市場的目標客戶群包括產業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過對全球犬流感疫苗市場進行分析時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- Zoetis Services LLC
- Merck & Co., Inc.
- Covetrus
- CSL Limited
- Boehringer Ingelheim Animal Health USA Inc.
- Elanco

第9章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI6932

Global Canine Influenza Vaccine Market is estimated to be valued at USD 2,006.2 Mn in 2026 and is expected to reach USD 2,918.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2,006.2 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.50%	2033 Value Projection:	USD 2,918.4 Mn

Canine influenza, commonly known as dog flu, is a contagious respiratory disease caused by influenza viruses that infect dogs. It is characterized by coughing, nasal discharge, and fever. While most dogs recover within 2-3 weeks, it can be fatal for young, old, or critically ill dogs. The global canine influenza vaccine market is driven by the growing cases of the virus across various regions. Increased awareness about the disease and availability of effective vaccination is supporting the market growth. However, lack of mandatory vaccination policies and high costs associated with vaccine production hampers the market potential. Overall, widespread R&D activities to develop new variants of the vaccine provide opportunities for market expansion in the coming years.

Market Dynamics

The global canine influenza vaccine market is witnessing a positive growth backed by the rising incidence of dog flu infections globally. As per research studies, the virus is widespread across North America, Asia Pacific, and several European countries. Growing dog ownership for companionship coupled with clustering of pets in kennels, dog shows, and parks aids in rapid transmission of the disease. This has boosted the demand for effective vaccination against canine influenza among pet owners and kennels. However, high capital investment required for vaccine production and lack of standard mass vaccination policies in some underdeveloped regions impedes the market growth. Moreover, constraints in supply chain disruptions due to the COVID-19 pandemic presented short-term challenges. Going forward, collaborative efforts from government agencies, vaccine developers, and veterinary practitioners to spread awareness about the illness and value of inoculation will create new opportunities.

Key Features of the Study

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global canine influenza vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study Zoetis Services LLC, Merck & Co., Inc., Covetrus, CSL Limited, and Boehringer Ingelheim Animal Health USA Inc., Elanco.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global canine influenza vaccine market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global canine influenza vaccine market.

Market Segmentation

By Vaccine Type (Revenue, USD Mn, 2021 - 2033)
Recombinant Vaccines
Inactivated Vaccines
Others
By Virus Type (Revenue, USD Mn, 2021 - 2033)
H3N8 virus
H3N2 virus
By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
Public
Private
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
Zoetis Services LLC
Merck & Co., Inc.
Covetrus
CSL Limited
Boehringer Ingelheim Animal Health USA Inc.
Elanco

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Virus Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Recent Developments
Regulatory Scenario
Manufacturer Revenue
Pricing Analysis
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Canine Influenza Vaccine Market, By Vaccine Type, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Recombinant Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Inactivated Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Canine Influenza Vaccine Market, By Virus Type, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
H3N8 virus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
H3N2 virus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Canine Influenza Vaccine Market, By Distribution Channel, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Public
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Canine Influenza Vaccine Market, By Region, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Zoetis Services LLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Covetrus
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- CSL Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim Animal Health USA Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Elanco
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies